-
Published 5/1/2024
Medina AR, Hammerness P, Ihyembe D, Plummer S, Diekroger E, Fogler J. Complex ADHD Challenging Case: Managing Co-Occurring Attention-Deficit Hyperactivity Disorder and Congenital Heart Disease with a Limited Medication Formulary: A Case from Mexico. J Dev Behav Pediatr. 2024 May-Jun 01; 45(3):e271-e273. PMID: 38905008.
-
Published 9/9/2023
Albanna A, Soubra K, Alhashmi D, Alloub Z, AlOlama F, Hammerness P, Lakshmanan J, Hechtman L, Hamoda H. Effectiveness of collaborative tele-mental health care for children with attention deficit hyperactivity disorder in United Arab Emirates. East Mediterr Health J. 2023 Sep 09; 29(9):742-748. PMID: 37776136.
-
Published 5/11/2022
Hammerness P, Berger A, Angelini MC, Wilens TE. Cardiovascular Considerations for Stimulant Class Medications. Child Adolesc Psychiatr Clin N Am. 2022 Jul; 31(3):437-448. PMID: 35697394.
-
Published 6/4/2021
Wilens TE, Faraone SV, Hammerness PG, Pliszka SR, Uchida CL, DeSousa NJ, Sallee FR, Incledon B, Newcorn JH. Clinically Meaningful Improvements in Early Morning and Late Afternoon/Evening Functional Impairment in Children with ADHD Treated with Delayed-Release and Extended-Release Methylphenidate. J Atten Disord. 2022 Mar; 26(5):696-705. PMID: 34085581.
-
Published 5/1/2021
Hammerness PG, Cassidy AR, Potts H, Richardson A, Fogler J, Daly KP, Augustyn M. Assessment and Treatment of a Young Adult with Congenital Heart Disease and ADHD. J Dev Behav Pediatr. 2021 05 01; 42(4):340-342. PMID: 33859122.